Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-17-010331
Filing Date
2017-05-10
Accepted
2017-05-10 17:16:44
Documents
51
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q tcon-10q_20170331.htm 10-Q 1375102
2 EX-31.1 tcon-ex311_114.htm EX-31.1 8871
3 EX-31.2 tcon-ex312_113.htm EX-31.2 8962
4 EX-32.1 tcon-ex321_112.htm EX-32.1 4897
5 EX-32.2 tcon-ex322_111.htm EX-32.2 4891
6 GRAPHIC g20170510161342734894.jpg GRAPHIC 41009
  Complete submission text file 0001564590-17-010331.txt   4814975

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT tcon-20170331.xml EX-101.INS 1008569
8 XBRL TAXONOMY EXTENSION SCHEMA tcon-20170331.xsd EX-101.SCH 41635
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE tcon-20170331_cal.xml EX-101.CAL 37127
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE tcon-20170331_def.xml EX-101.DEF 111177
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE tcon-20170331_lab.xml EX-101.LAB 276517
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tcon-20170331_pre.xml EX-101.PRE 200277
Mailing Address 8910 UNIVERSITY CENTER DRIVE SUITE 700 San Diego CA 92122
Business Address 8910 UNIVERSITY CENTER DRIVE SUITE 700 San Diego CA 92122 858-550-0780
Tracon Pharmaceuticals, Inc. (Filer) CIK: 0001394319 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36818 | Film No.: 17831528
SIC: 2836 Biological Products, (No Diagnostic Substances)